Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
crispr
3
×
editas medicine
life sciences
national blog main
3
×
biotech
crispr-cas9
gene editing
katrine bosley
national
national top stories
san francisco blog main
san francisco top stories
advaxis
aimmune therapeutics
alder biopharmaceuticals
alexander hardy
allergan
andrew oxtoby
babies
boston
boulder/denver blog main
boulder/denver top stories
breakup
bridge bio pharma
cancer
ceo
clinical hold
clinical study
clinical trials
combination
commissioner
congress
crispr therapeutics
cynthia collins
delisting
democrats
departure
detroit blog main
What
crispr
3
×
medicine
3
×
cas
ceo
editas
editing
gene
katrine
allergan
big
bio
blessing
bosley
bosley's
bosley’s
bridge
bucks
cancer
cells
check
clinical
crime
cusp
defect
depart
departure
drive
edited
exit
experimental
fears
flag
genetic
guardian
guiding
human
humans
known
lab
malfunction
Language
Current search:
crispr
×
crispr
×
" national blog main "
×
medicine
×
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
@xconomy.com
5 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells